Literature DB >> 36194357

Upregulated Ribosomal Pathway Impairs Follicle Development in a Polycystic Ovary Syndrome Mouse Model: Differential Gene Expression Analysis of Oocytes.

Natsuki Nakanishi1,2, Satoko Osuka3, Tomohiro Kono4, Hisato Kobayashi4, Shinya Ikeda4, Bayasula Bayasula3, Reina Sonehara3, Mayuko Murakami3, Sayako Yoshita3, Natsuki Miyake3, Ayako Muraoka3, Yukiyo Kasahara3, Tomohiko Murase3, Tomoko Nakamura3, Maki Goto3, Akira Iwase5, Hiroaki Kajiyama3.   

Abstract

Polycystic ovary syndrome (PCOS), a common endocrine disorder, is associated with impaired oocyte development, leading to infertility. However, the pathogenesis of PCOS has not been completely elucidated. This study aimed to determine the differentially expressed genes (DEGs) and epigenetic changes in the oocytes from a PCOS mouse model to identify the etiological factors. RNA-sequencing analysis revealed that 90 DEGs were upregulated and 27 DEGs were downregulated in mice with PCOS compared with control mice. DNA methylation analysis revealed 30 hypomethylated and 10 hypermethylated regions in the PCOS group. However, the DNA methylation status did not correlate with differential gene expression. The pathway enrichment analysis revealed that five DEGs (Rps21, Rpl36, Rpl36a, Rpl37a, and Rpl22l1) were enriched in ribosome-related pathways in the oocytes of mice with PCOS, and the immunohistochemical analysis revealed significantly upregulated expression levels of Rps21 and Rpl36. These results suggest that differential gene expression in the oocytes of mice in PCOS is related to impaired folliculogenesis. These findings improve our understanding of PCOS pathogenesis.
© 2022. The Author(s), under exclusive licence to Society for Reproductive Investigation.

Entities:  

Keywords:  Infertility; Oocyte; Polycystic ovary syndrome; Rpl36; Rps21

Year:  2022        PMID: 36194357     DOI: 10.1007/s43032-022-01095-7

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  48 in total

Review 1.  What is polycystic ovary syndrome? Are national views important?

Authors:  Adam Balen; Kathy Michelmore
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

2.  Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.

Authors:  Yongyong Shi; Han Zhao; Yuhua Shi; Yunxia Cao; Dongzi Yang; Zhiqiang Li; Bo Zhang; Xiaoyan Liang; Tao Li; Jianhua Chen; Jiawei Shen; Junzhao Zhao; Li You; Xuan Gao; Dongyi Zhu; Xiaoming Zhao; Ying Yan; Yingying Qin; Wenjin Li; Junhao Yan; Qingzhong Wang; Junli Zhao; Ling Geng; Jinlong Ma; Yueran Zhao; Guang He; Aiping Zhang; Shuhua Zou; Aijun Yang; Jiayin Liu; Weidong Li; Baojie Li; Chunling Wan; Ying Qin; Juanzi Shi; Jing Yang; Hong Jiang; Jin-e Xu; Xiujuan Qi; Yun Sun; Yajie Zhang; Cuifang Hao; Xiuqing Ju; Dongni Zhao; Chun-e Ren; Xiuqing Li; Wei Zhang; Yiwen Zhang; Jiangtao Zhang; Di Wu; Changming Zhang; Lin He; Zi-Jiang Chen
Journal:  Nat Genet       Date:  2012-08-12       Impact factor: 38.330

3.  Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome.

Authors:  Jaye Adams; Zhilin Liu; Yi Athena Ren; Wan-Song Wun; Wei Zhou; Shlomit Kenigsberg; Clifford Librach; Cecilia Valdes; William Gibbons; JoAnne Richards
Journal:  J Clin Endocrinol Metab       Date:  2016-05-26       Impact factor: 5.958

4.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Authors:  Helena J Teede; Marie L Misso; Michael F Costello; Anuja Dokras; Joop Laven; Lisa Moran; Terhi Piltonen; Robert J Norman
Journal:  Hum Reprod       Date:  2018-09-01       Impact factor: 6.918

5.  Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.

Authors:  Vibe Skov; Dorte Glintborg; Steen Knudsen; Qihua Tan; Thomas Jensen; Torben A Kruse; Henning Beck-Nielsen; Kurt Højlund
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

6.  Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.

Authors:  Felix R Day; David A Hinds; Joyce Y Tung; Lisette Stolk; Unnur Styrkarsdottir; Richa Saxena; Andrew Bjonnes; Linda Broer; David B Dunger; Bjarni V Halldorsson; Debbie A Lawlor; Guillaume Laval; Iain Mathieson; Wendy L McCardle; Yvonne Louwers; Cindy Meun; Susan Ring; Robert A Scott; Patrick Sulem; André G Uitterlinden; Nicholas J Wareham; Unnur Thorsteinsdottir; Corrine Welt; Kari Stefansson; Joop S E Laven; Ken K Ong; John R B Perry
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

7.  Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity.

Authors:  Michelle R Jones; Meredith A Brower; Ning Xu; Jinrui Cui; Emebet Mengesha; Yii-Der I Chen; Kent D Taylor; Ricardo Azziz; Mark O Goodarzi
Journal:  PLoS Genet       Date:  2015-08-25       Impact factor: 5.917

8.  Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.

Authors:  Xiu-Xia Wang; Jing-Zan Wei; Jiao Jiao; Shu-Yi Jiang; Da-Hai Yu; Da Li
Journal:  Oncotarget       Date:  2014-08-30

9.  Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS.

Authors:  Xin Huang; Jiaping Pan; Bi Wu; Xiaoming Teng
Journal:  Reprod Biol Endocrinol       Date:  2018-08-03       Impact factor: 5.211

10.  Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.

Authors:  M Geoffrey Hayes; Margrit Urbanek; David A Ehrmann; Loren L Armstrong; Ji Young Lee; Ryan Sisk; Tugce Karaderi; Thomas M Barber; Mark I McCarthy; Stephen Franks; Cecilia M Lindgren; Corrine K Welt; Evanthia Diamanti-Kandarakis; Dimitrios Panidis; Mark O Goodarzi; Ricardo Azziz; Yi Zhang; Roland G James; Michael Olivier; Ahmed H Kissebah; Elisabet Stener-Victorin; Richard S Legro; Andrea Dunaif
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.